tamsulosin
Brand: Flomax
Prototype: doxazosin
Drug Class: selective alpha-1A/1D adrenergic antagonist
Drug Family: GU agent
Subclass: uroselective alpha-1 blocker
Organ Systems: reproductivecardiovascular
Mechanism of Action
Selective antagonist of alpha-1A and alpha-1D adrenergic receptors in the prostate, bladder neck, and urethra. Blockade relaxes smooth muscle in these structures, reducing urethral resistance and improving urinary flow rate in benign prostatic hyperplasia (BPH). More uroselective than doxazosin or terazosin, producing less systemic hypotension.
alpha-1A adrenergic receptors (prostate, bladder neck, urethra)alpha-1D receptors (detrusor)
Indications
- benign prostatic hyperplasia (BPH) — symptomatic lower urinary tract symptoms
- ureteral calculi (facilitates passage — off-label)
Contraindications
- hypersensitivity to tamsulosin
- caution with strong CYP3A4 inhibitors
Adverse Effects
Common
- dizziness
- orthostatic hypotension (less than non-selective alpha-blockers)
- rhinitis
- ejaculatory dysfunction (retrograde ejaculation)
- headache
Serious
- intraoperative floppy iris syndrome (IFIS) — iris floppiness during cataract surgery
- priapism (rare)
- first-dose hypotension (less common than non-selective alpha-blockers)
Pharmacokinetics (ADME)
| Absorption | oral bioavailability ~100%; slow absorption due to modified-release capsule |
| Distribution | 94–99% protein bound |
| Metabolism | hepatic via CYP3A4 and CYP2D6 |
| Excretion | renal (76%) |
| Half-life | 9–13 hours |
| Onset | days to 2 weeks |
| Peak | 4–6 hours |
| Duration | 24 hours |
| Protein Binding | 94–99% |
| Vd | 16 L |
Drug Interactions
| Drug / Agent | Mechanism | Severity |
|---|---|---|
| PDE-5 inhibitors (sildenafil, tadalafil) | additive blood pressure lowering; use cautiously; separate timing if possible | moderate |
| strong CYP3A4 inhibitors (ketoconazole) | increase tamsulosin exposure; use with caution | moderate |
Nursing Considerations
- CRITICAL: Inform ophthalmologist about tamsulosin use BEFORE any eye surgery, especially cataract surgery. IFIS (intraoperative floppy iris syndrome) can cause surgical complications even after tamsulosin is discontinued.
- Administer 30 minutes after the same meal each day to maintain consistent drug levels.
- Counsel patients about orthostatic hypotension risk, especially during initial therapy; rise slowly from sitting/lying position.
- Ejaculatory dysfunction (retrograde ejaculation) is common but reversible upon discontinuation; discuss with patients who are planning conception.
Clinical Pearls
- Tamsulosin's uroselective alpha-1A receptor profile means it produces significantly less orthostatic hypotension than non-selective alpha-blockers (doxazosin, prazosin, terazosin), but the IFIS risk during cataract surgery persists even months after discontinuation.
- Alpha-1 blockers provide rapid symptomatic relief of BPH (within days), while 5-alpha reductase inhibitors (finasteride, dutasteride) require months for effect but reduce prostate volume and long-term risk of urinary retention.
Safety Profile
Pregnancy use-with-caution
Lactation use-with-caution
Renal Adjustment Not required
Hepatic Adjustment Not required
TDM Not required
Concordance Terms
Cross-referenced clinical concepts — click any term to see all content where it appears.